mediscan diagnostic services ltd Company Information
Group Structure
View All
Industry
General medical practice activities
Registered Address
unit b2- 36, tameside business park, windmill, manchester, M34 3QS
Website
www.mediscanservices.co.ukmediscan diagnostic services ltd Estimated Valuation
Pomanda estimates the enterprise value of MEDISCAN DIAGNOSTIC SERVICES LTD at £929k based on a Turnover of £1.6m and 0.57x industry multiple (adjusted for size and gross margin).
mediscan diagnostic services ltd Estimated Valuation
Pomanda estimates the enterprise value of MEDISCAN DIAGNOSTIC SERVICES LTD at £539.9k based on an EBITDA of £127.3k and a 4.24x industry multiple (adjusted for size and gross margin).
mediscan diagnostic services ltd Estimated Valuation
Pomanda estimates the enterprise value of MEDISCAN DIAGNOSTIC SERVICES LTD at £300.7k based on Net Assets of £119.7k and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Mediscan Diagnostic Services Ltd Overview
Mediscan Diagnostic Services Ltd is a live company located in manchester, M34 3QS with a Companies House number of 06228910. It operates in the general medical practice activities sector, SIC Code 86210. Founded in April 2007, it's largest shareholder is erum noman with a 99% stake. Mediscan Diagnostic Services Ltd is a established, small sized company, Pomanda has estimated its turnover at £1.6m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Mediscan Diagnostic Services Ltd Health Check
Pomanda's financial health check has awarded Mediscan Diagnostic Services Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs


1 Strong

3 Regular

7 Weak

Size
annual sales of £1.6m, make it in line with the average company (£2m)
- Mediscan Diagnostic Services Ltd
£2m - Industry AVG

Growth
3 year (CAGR) sales growth of -42%, show it is growing at a slower rate (10.5%)
- Mediscan Diagnostic Services Ltd
10.5% - Industry AVG

Production
with a gross margin of 39.9%, this company has a comparable cost of product (39.9%)
- Mediscan Diagnostic Services Ltd
39.9% - Industry AVG

Profitability
an operating margin of 2.4% make it less profitable than the average company (3.7%)
- Mediscan Diagnostic Services Ltd
3.7% - Industry AVG

Employees
with 11 employees, this is below the industry average (23)
11 - Mediscan Diagnostic Services Ltd
23 - Industry AVG

Pay Structure
on an average salary of £34.6k, the company has an equivalent pay structure (£34.6k)
- Mediscan Diagnostic Services Ltd
£34.6k - Industry AVG

Efficiency
resulting in sales per employee of £147.7k, this is more efficient (£86.6k)
- Mediscan Diagnostic Services Ltd
£86.6k - Industry AVG

Debtor Days
it gets paid by customers after 53 days, this is later than average (30 days)
- Mediscan Diagnostic Services Ltd
30 days - Industry AVG

Creditor Days
its suppliers are paid after 18 days, this is quicker than average (25 days)
- Mediscan Diagnostic Services Ltd
25 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Mediscan Diagnostic Services Ltd
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 5 weeks, this is less cash available to meet short term requirements (39 weeks)
5 weeks - Mediscan Diagnostic Services Ltd
39 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 86.8%, this is a higher level of debt than the average (55.9%)
86.8% - Mediscan Diagnostic Services Ltd
55.9% - Industry AVG
MEDISCAN DIAGNOSTIC SERVICES LTD financials

Mediscan Diagnostic Services Ltd's latest turnover from March 2024 is estimated at £1.6 million and the company has net assets of £119.7 thousand. According to their latest financial statements, Mediscan Diagnostic Services Ltd has 11 employees and maintains cash reserves of £65.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 11 | 11 | 9 | 123 | 142 | 165 | |||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 606,893 | 592,097 | 740,597 | 873,193 | 684,071 | 492,885 | 388,091 | 252,461 | 233,282 | 191,662 | 87,902 | 85,613 | 1,837 | 2,449 | |
Intangible Assets | 3,266 | ||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 606,893 | 592,097 | 740,597 | 873,193 | 684,071 | 492,885 | 388,091 | 252,461 | 233,282 | 191,662 | 87,902 | 85,613 | 1,837 | 2,449 | 3,266 |
Stock & work in progress | |||||||||||||||
Trade Debtors | 236,189 | 126,859 | 395,994 | 1,119,878 | 754,620 | 589,473 | 577,843 | 588,615 | 695,032 | 341,334 | 298,302 | 99,289 | 1 | 5,968 | |
Group Debtors | |||||||||||||||
Misc Debtors | 64,348 | 45,000 | 85,300 | 65,300 | 65,300 | 6,276 | |||||||||
Cash | 65,329 | 29,627 | 186,165 | 210,755 | 427,181 | 267,686 | 276,477 | 444,363 | 156,672 | 414,633 | 329,965 | 146,085 | 46,140 | 7,534 | 159 |
misc current assets | |||||||||||||||
total current assets | 301,518 | 220,834 | 627,159 | 1,415,933 | 1,247,101 | 922,459 | 854,320 | 1,032,978 | 857,980 | 755,967 | 628,267 | 245,374 | 46,140 | 7,535 | 6,127 |
total assets | 908,411 | 812,931 | 1,367,756 | 2,289,126 | 1,931,172 | 1,415,344 | 1,242,411 | 1,285,439 | 1,091,262 | 947,629 | 716,169 | 330,987 | 47,977 | 9,984 | 9,393 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 48,218 | 10,428 | 56,374 | 358,472 | 592,885 | 308,600 | 142,938 | 133,116 | 110,621 | 619,541 | 476,634 | 330,738 | 39,906 | 2,148 | 6,252 |
Group/Directors Accounts | 23,972 | 50,012 | 152,957 | 7,586 | 285,704 | 214,784 | |||||||||
other short term finances | |||||||||||||||
hp & lease commitments | 85,180 | 85,180 | 85,180 | 85,180 | 78,163 | 63,397 | 172,621 | 82,621 | 84,450 | ||||||
other current liabilities | 475,025 | 285,934 | 263,194 | 406,152 | 260,827 | 152,868 | 364,636 | 270,063 | 356,479 | ||||||
total current liabilities | 608,423 | 381,542 | 404,748 | 873,776 | 981,887 | 677,822 | 687,781 | 771,504 | 766,334 | 619,541 | 476,634 | 330,738 | 39,906 | 2,148 | 6,252 |
loans | 19,980 | 37,035 | 41,630 | 50,000 | |||||||||||
hp & lease commitments | 160,259 | 303,573 | 308,925 | 354,004 | 80,425 | 118,004 | |||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | 180,239 | 340,608 | 350,555 | 404,004 | 80,425 | 118,004 | |||||||||
total liabilities | 788,662 | 722,150 | 755,303 | 1,277,780 | 1,062,312 | 795,826 | 687,781 | 771,504 | 766,334 | 619,541 | 476,634 | 330,738 | 39,906 | 2,148 | 6,252 |
net assets | 119,749 | 90,781 | 612,453 | 1,011,346 | 868,860 | 619,518 | 554,630 | 513,935 | 324,928 | 328,088 | 239,535 | 249 | 8,071 | 7,836 | 3,141 |
total shareholders funds | 119,749 | 90,781 | 612,453 | 1,011,346 | 868,860 | 619,518 | 554,630 | 513,935 | 324,928 | 328,088 | 239,535 | 249 | 8,071 | 7,836 | 3,141 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 87,912 | 148,500 | 120,900 | 155,464 | 147,617 | 115,650 | 116,331 | 86,327 | 65,497 | 35,968 | 17,711 | 2,748 | 612 | 1,088 | |
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | |||||||||||||||
Debtors | 44,982 | -249,787 | -764,184 | 385,258 | 165,147 | 76,930 | -10,772 | -112,693 | 359,974 | 43,032 | 199,013 | 99,289 | -1 | -5,967 | 5,968 |
Creditors | 37,790 | -45,946 | -302,098 | -234,413 | 284,285 | 165,662 | 9,822 | 22,495 | -508,920 | 142,907 | 145,896 | 290,832 | 37,758 | -4,104 | 6,252 |
Accruals and Deferred Income | 189,091 | 22,740 | -142,958 | 145,325 | 107,959 | -211,768 | 94,573 | -86,416 | 356,479 | ||||||
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -23,972 | -26,040 | -102,945 | 145,371 | -278,118 | 70,920 | 214,784 | ||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | -17,055 | -4,595 | -8,370 | 50,000 | |||||||||||
Hire Purchase and Lease Commitments | -143,314 | -5,352 | -45,079 | 280,596 | -22,813 | 8,780 | 90,000 | -1,829 | 84,450 | ||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 35,702 | -156,538 | -24,590 | -216,426 | 159,495 | -8,791 | -167,886 | 287,691 | -257,961 | 84,668 | 183,880 | 99,945 | 38,606 | 7,375 | 159 |
overdraft | |||||||||||||||
change in cash | 35,702 | -156,538 | -24,590 | -216,426 | 159,495 | -8,791 | -167,886 | 287,691 | -257,961 | 84,668 | 183,880 | 99,945 | 38,606 | 7,375 | 159 |
mediscan diagnostic services ltd Credit Report and Business Information
Mediscan Diagnostic Services Ltd Competitor Analysis

Perform a competitor analysis for mediscan diagnostic services ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in M34 area or any other competitors across 12 key performance metrics.
mediscan diagnostic services ltd Ownership
MEDISCAN DIAGNOSTIC SERVICES LTD group structure
Mediscan Diagnostic Services Ltd has no subsidiary companies.
Ultimate parent company
MEDISCAN DIAGNOSTIC SERVICES LTD
06228910
mediscan diagnostic services ltd directors
Mediscan Diagnostic Services Ltd currently has 1 director, Mrs Erum Noman serving since Jun 2022.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Erum Noman | England | 50 years | Jun 2022 | - | Director |
P&L
March 2024turnover
1.6m
+105%
operating profit
39.3k
0%
gross margin
39.9%
-3.18%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
119.7k
+0.32%
total assets
908.4k
+0.12%
cash
65.3k
+1.21%
net assets
Total assets minus all liabilities
mediscan diagnostic services ltd company details
company number
06228910
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
April 2007
age
18
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
rad tec (london) ltd (January 2012)
accountant
-
auditor
-
address
unit b2- 36, tameside business park, windmill, manchester, M34 3QS
Bank
-
Legal Advisor
-
mediscan diagnostic services ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to mediscan diagnostic services ltd.
mediscan diagnostic services ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDISCAN DIAGNOSTIC SERVICES LTD. This can take several minutes, an email will notify you when this has completed.
mediscan diagnostic services ltd Companies House Filings - See Documents
date | description | view/download |
---|